Berberoǧlu,, M., Evliyaoǧlu,, O., Adıyaman,, P., Öcal,, G., Ulukol,, Β., Şimşek,, F., Şıklar,, Ζ., Törel,, Α., Özel,, D. and Akar,, N.. "Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphism (-675 4G/SG) Associated with Obesity and Vascular Risk in Children"
Journal of Pediatric Endocrinology and Metabolism, vol. 19, no. 5, 2006, pp. 741-748.
https://doi.org/10.1515/JPEM.2006.19.5.741Berberoǧlu,, M., Evliyaoǧlu,, O., Adıyaman,, P., Öcal,, G., Ulukol,, Β., Şimşek,, F., Şıklar,, Ζ., Törel,, Α., Özel,, D. & Akar,, N. (2006). Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphism (-675 4G/SG) Associated with Obesity and Vascular Risk in Children.
Journal of Pediatric Endocrinology and Metabolism,
19(5), 741-748.
https://doi.org/10.1515/JPEM.2006.19.5.741Berberoǧlu,, M., Evliyaoǧlu,, O., Adıyaman,, P., Öcal,, G., Ulukol,, Β., Şimşek,, F., Şıklar,, Ζ., Törel,, Α., Özel,, D. and Akar,, N. (2006) Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphism (-675 4G/SG) Associated with Obesity and Vascular Risk in Children. Journal of Pediatric Endocrinology and Metabolism, Vol. 19 (Issue 5), pp. 741-748.
https://doi.org/10.1515/JPEM.2006.19.5.741Berberoǧlu,, M., Evliyaoǧlu,, O., Adıyaman,, P., Öcal,, G., Ulukol,, Β., Şimşek,, F., Şıklar,, Ζ., Törel,, Α., Özel,, D. and Akar,, N.. "Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphism (-675 4G/SG) Associated with Obesity and Vascular Risk in Children"
Journal of Pediatric Endocrinology and Metabolism 19, no. 5 (2006): 741-748.
https://doi.org/10.1515/JPEM.2006.19.5.741Berberoǧlu, M, Evliyaoǧlu, O, Adıyaman, P, Öcal, G, Ulukol, Β, Şimşek, F, Şıklar, Ζ, Törel, Α, Özel, D, Akar, N. Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphism (-675 4G/SG) Associated with Obesity and Vascular Risk in Children.
Journal of Pediatric Endocrinology and Metabolism. 2006;19(5): 741-748.
https://doi.org/10.1515/JPEM.2006.19.5.741Copied to clipboard
